Defymed

France
Alsace, France, Strasbourg
+33390410446 ★

Company profile

Defymed company profile

Defymed is a worldwide leader in the development of innovative implantable medical devices that change the paradigm of therapeutics' administration. Defymed's innovations were developed to limit adverse events related to current standard of care based on site specific delivery of therapeutics. Our solutions aim for a precise administration of drugs, in a physiologic site, in order to improve disease's management and patients' quality of life. Up to date, two first in class technologies were developed by Defymed: MailPan®, a physiologic cell encapsulation device, and ExOlin®, a targeted drug delivery device (in clinics). Defymed owns an exclusive technology and know-how which..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Phone number
+33390410446
Operating status
Closed
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2011-03-07

Headquarters

Headquarters
Alsace, France, Strasbourg
Postal code
67200
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
4
Total equity funding
$5.5M
Last funding
Seed / $1.1M / 2020-05-05
Last equity funding
Seed / $1.1M
Investors
5
Lead investors
1
Founders
1
Articles
7
Closed on
2023-01-01

Founders and investors

Founders

Séverine Sigrist

Lead investors

Cap Innov'Est

Investors

Cap Innov'EstCeeD (Centre Européen d'étude du diabète)CTTMEmertecStatice

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.